Top Buy
| Security | Buy | Sell | Buy (1M) ▲ | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Fresenius SE & Co. KGaA | 4 | 0 | 2 | 0 | €27.33 | - | - |
| Cara Therapeutics Inc. | 8 | 1 | 2 | 0 | €0.64 | €4.63 | 625.596% |
| Stoke Therapeutics Inc | 15 | 1 | 2 | 0 | €10.60 | €21.39 | 101.821% |
| Merit Medical Systems | 13 | 0 | 2 | 0 | €68.50 | €86.72 | 26.594% |
| Innoviva Inc. | 3 | 0 | 2 | 0 | €14.20 | €30.00 | 111.268% |
| Hologic Inc. | 13 | 0 | 2 | 0 | €71.00 | €84.03 | 18.355% |
| Acorda Therapeutics Cdt | 15 | 0 | 2 | 0 | €0.47 | - | - |
| Kala Pharmaceuticals Inc. | 4 | 0 | 2 | 0 | €6.00 | €19.86 | 231.082% |
| Bausch Health Companies Inc. | 4 | 0 | 2 | 0 | €8.15 | €16.47 | 102.263% |
| Laboratory Corp. Of America (labcorp) | 11 | 0 | 2 | 0 | €186.00 | €237.94 | 27.925% |
| Akebia Therapeutics Inc. | 8 | 3 | 2 | 1 | €1.25 | €3.60 | 188.389% |
| Vanda Pharmaceuticals | 4 | 0 | 2 | 0 | €4.32 | €5.00 | 15.741% |
| Cellectar BioSciences Inc. | 7 | 9 | 2 | 1 | €2.84 | €10.55 | 271.331% |
| Viracta Therapeutics Inc. | 2 | 0 | 2 | 0 | €0.81 | - | - |
| Geron Corp. | 10 | 0 | 2 | 0 | €3.54 | €4.59 | 29.867% |
| R1 RCM Inc. | 19 | 0 | 2 | 0 | €10.70 | €17.21 | 60.865% |
| Masimo Corp. | 7 | 1 | 2 | 0 | €127.20 | €147.62 | 16.050% |
| Atossa Genetics Inc | 5 | 1 | 2 | 0 | €1.43 | €3.72 | 160.757% |
| Rhythm Pharmaceuticals | 14 | 0 | 2 | 0 | €36.60 | €46.08 | 25.908% |
| Corcept Therapeutics Inc. | 9 | 0 | 2 | 0 | €21.32 | €33.55 | 57.348% |
| HCA Holdings Inc. | 18 | 0 | 2 | 0 | €286.50 | €289.63 | 1.091% |
| Universal Health Services B | 9 | 3 | 2 | 1 | €154.00 | €159.70 | 3.704% |
| Agios Pharmaceuticals Inc. | 5 | 0 | 2 | 0 | €29.60 | €38.99 | 31.718% |
| Trinity Biotech ADR | 23 | 0 | 2 | 0 | €0.41 | - | - |
| Novo Nordisk A/S ADR | 17 | 1 | 3 | 0 | €119.00 | €130.44 | 9.612% |